Vonjo (Pacritinib): Uses, Side Effects & Interactions
1. Introduction and Mechanism of Action for Vonjo Vonjo contains the active pharmaceutical ingredient pacritinib, which is a targeted kinase inhibitor primarily prescribed for adults with intermediate or high-risk primary or secondary myelofibrosis. The most notable side effects of this therapy include severe gastrointestinal toxicity and hematological suppression, specifically worsening thrombocytopenia. By selectively inhibiting Janus … Read more